[1]
2026. PHARMACOLOGICAL EVALUATION OF ISOXANTHOHUMOL IN ALCL3 INDUCED ALZHEIMER DISEASE. The Research of Medical Science Review. 4, 4 (Apr. 2026), 305–314.